What is Semaglutide?
Semaglutide can help control your cravings, blood sugar regulation, and appetite to achieve significant weight loss! Semaglutide is an FDA-approved prescription for weight management.
- Semaglutide is a weight loss medication received by weekly injection
- Semaglutide is FDA-approved for weight loss
- Semaglutide is more effective than all prior weight loss medications!
How Does Semaglutide Work?
- Slows down stomach emptying so that after eating, you feel full longer
- Suppresses appetite and food cravings (on average, patients eat ~30% less)
- Lowers blood glucose levels (without making glucose levels too low)
Your body naturally produces several substances that affect your appetite. One of these is called glucagon-like peptide-1 (GLP-1). The body produces GLP-1 naturally when you eat. GLP-1 stops you from feeling hungry and makes you feel full or satisfied.
Semaglutide imitates GLP-1 in the body. This means that Semaglutide provides the same effect as this natural substance (GLP-1) in our bodies.
Reduced food intake: Because Semaglutide reduces feelings of hunger, you eat less food. When combined with a healthy diet, exercise and everything @Chill Cryotherapy, Semaglutide will help you lose weight!
Effect on plaques in your blood vessels: In animal studies, Semaglutide stopped the progression of plaque formation in blood vessels. This is likely why Semaglutide has also been shown to reduce the risk of cardiovascular events and strokes.
Who Can Take Semaglutide?
Adult and teenage patients who are looking to lose weight! Semaglutide is FDA-approved for adults & teenagers with a BMI of 27 or above,
Our physicians and nurse practitioners will evaluate you and determine if semaglutide can help you lose weight to live a healthier life!
Semaglutide is extremely effective in helping obese and overweight patients lose weight. It is safe for individuals with hypertension, type-2 diabetes, and dyslipidemia.
Who Cannot Take Semaglutide?
You CAN NOT take Semaglutide if you have any of the following conditions:
- personal or family history of Medullary Thyroid Carcinoma (MTC)
- personal or family history of Multiple Endocrine Neoplasia, type 2 (MEN 2)
- prior allergic reaction to Semaglutide or to any of its ingredients*
- diabetic retinopathy (diabetic eye disease)
- pregnant or trying to get pregnant
- breast-feeding (Semaglutide is present in breast milk)
- depression with a history of suicidal thoughts
- history of pancreatitis
- kidney disease/kidney insufficiency
- stomach problems
- diabetes—you must obtain approval for use from endocrinology or primary care physician)
What Are the Ingredients in Semaglutide?
Active Ingredient: Semaglutide and Vitamin B12 (cyanocobalamin)
We include vitamin B12 with our semaglutide injections in order to reduce the incidence of nausea or stomach upset.
Frequently Asked Questions
How can I get Semaglutide through Chill Cryotherapy?
Step 1: fill out our medical intake and consent form
Step 2: Meet with our physician virtually to determine your suitability for semaglutide treatment
Step 3: Per the physician’s instructions, you will receive once-weekly injections of semaglutide at Chill.
Step 4: Continue to eat a healthy diet, exercise, and utilize Chill Cryotherapy services to stimulate metabolic boost and weight loss!
Click here to fill out the medical history intake and consent for Semaglutide
What results can I expect from semaglutide therapy?
Semaglutide has been described by doctors as twice as effective as any prescription weight loss product on the market today, likening it to the equivalent of having gastric bypass surgery.
Semaglutide trial results showed overweight or obese adults receiving weekly semaglutide had a mean weight loss of 14.9% at 68 weeks. In this same study, nearly 70% of participants were able to achieve a 10% weight loss threshold by taking semaglutide. And 32% of participants lost at least 20% of their initial weight.
What are the additional effects of Semaglutide (in addition to weight loss!)
- improved fertility
- smoking cessation
- cardiovascular benefits
- relieve PCOS
How is semaglutide administered?
Semaglutide is a subcutaneous injection, usually administered once weekly. Dosing may be increased after one month if needed.
What are the possible side effects of semaglutide?”
The most commonly reported side effects are nausea, vomiting, diarrhea, stomach pain, and constipation. The risk of serious side effects increases in patients with hypoglycemia, kidney problems, and a high risk for allergic reactions.
Is semaglutide the same thing as Ozempic or Wegovy?
Ozempic and Wegovy are two brand names that are used for marketing injectable semaglutide. Ozempic is used for type 2 diabetes, with a secondary benefit of weight loss, while Wegovy was formulated specifically for weight loss. Both of these brand-name medications contain semaglutide! Semaglutide is the peptide found in both of these brand-name medications. The benefit of getting semaglutide through Chill Cryotherapy is that you will pay a lot less for the same medication!
Can I get semaglutide from Chill Cryotherapy and give myself the injections?
Yes! We can offer direct shipping of your semaglutide injections if you are not able to come into Chill for your injections. We are licensed to offer semaglutide in New Jersey, New York, Ohio, and Florida.
We offer several options:
- Initial Physician Consult plus 1st month of Semaglutide: $449
- Initial Physician Consult plus 3 months of Semaglutide: $997
- After Your 1st – Month 4 Injections of .25mg OR .5mg $299
- Month 3 = 4 injections @1.0 mg: $349
- Month 4 = 4 injections @1.7mg: $399
- Month 5 = 4 injections @2.4mg: $499
Follow-up consultation with physician or physician extender if required: $99.
Research Articles and Clinical Trials
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity The STEP 4 Randomized Clinical Trial
Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials
FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014